NIH begins clinical trial of hydroxychloroquine and azithromycin to treat coronavirus patients

NIH doses first coronavirus patient in trial of hydroxychloroquine and antibiotic combo touted by Trump in hopes the controversial drug will cut risks of hospitalization and death The NIH has begun a clinical trial testing anti-malaria drug hydroxychloroquine and antibiotic azithromycin in coronavirus patients Patients will either be assigned the experimental treatment or a pair … Read more

Triple-drug combo of hydroxychloroquine, azithromycin and ZINC helped COVID-19 patients

Combining the anti-malaria drug hydroxychloroquine with the dietary supplement zincĀ could create a more effective treatment for coronavirus patients, a new study suggests. Researchers found that taking the drugs together, along with the antibiotic azithromycin, increased patient’s chances of being discharged and decreased their risk of dying. It did not, however, change the average time patients … Read more